TOF-话题@MedSci

#TOF#

24篇内容 | 835人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1987494, encodeId=dd24198e4945b, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=A&R：鉴定Mitofusin 1和补体成分1q亚成分结合蛋白作为系统性红斑狼疮的线粒体靶点, objectType=article, longId=733146, objectId=feafe331462d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feafe331462d, replyNumber=0, likeNumber=38, createdTime=2022-09-20, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feafe331462d, moduleTitle=A&R：鉴定Mitofusin 1和补体成分1q亚成分结合蛋白作为系统性红斑狼疮的线粒体靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feafe331462d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987493, encodeId=36f3198e49339, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=J Am Acad Dermatol：外用JAK-STAT抑制剂Tofacitinib有效减少非特应性皮炎慢性瘙痒, objectType=article, longId=301104, objectId=bf1030110428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf1030110428, replyNumber=0, likeNumber=41, createdTime=2022-10-02, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf1030110428, moduleTitle=J Am Acad Dermatol：外用JAK-STAT抑制剂Tofacitinib有效减少非特应性皮炎慢性瘙痒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf1030110428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987492, encodeId=27b5198e492df, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=European Radiology:应用TOF-MRA，做到颅内动脉狭窄的无创精准分析！, objectType=article, longId=299263, objectId=20ec2992638a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20ec2992638a, replyNumber=0, likeNumber=42, createdTime=2022-03-14, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20ec2992638a, moduleTitle=European Radiology:应用TOF-MRA，做到颅内动脉狭窄的无创精准分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20ec2992638a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987491, encodeId=fde3198e491ef, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Nat Commun：Tofacitinib治疗系统性红斑狼疮的1期临床试验结果, objectType=article, longId=212458, objectId=485a21245897, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=485a21245897, replyNumber=0, likeNumber=31, createdTime=2021-12-05, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=485a21245897, moduleTitle=Nat Commun：Tofacitinib治疗系统性红斑狼疮的1期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=485a21245897)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987490, encodeId=c769198e49081, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=XELJANZ（tofacitinib）治疗强直性脊柱炎（AS）：III期研究取得阳性结果, objectType=article, longId=203133, objectId=529b20313392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=529b20313392, replyNumber=0, likeNumber=40, createdTime=2021-06-19, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=529b20313392, moduleTitle=XELJANZ（tofacitinib）治疗强直性脊柱炎（AS）：III期研究取得阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=529b20313392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987489, encodeId=7cc9198e489d3, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=NEJM：Tofersen治疗SOD1-ALS, objectType=article, longId=197292, objectId=7fa719e292b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa719e292b4, replyNumber=0, likeNumber=41, createdTime=2021-04-30, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa719e292b4, moduleTitle=NEJM：Tofersen治疗SOD1-ALS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fa719e292b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987484, encodeId=32ae198e48413, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Clin Chem：一种应用于尿碱症的全面LC-QTOF-MS代谢表型分析策略研究, objectType=article, longId=175826, objectId=5d011e582659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d011e582659, replyNumber=0, likeNumber=39, createdTime=2019-11-21, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d011e582659, moduleTitle=Clin Chem：一种应用于尿碱症的全面LC-QTOF-MS代谢表型分析策略研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d011e582659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987486, encodeId=8468198e486b1, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Clin Chem：免疫富集-偶联MALDI-TOF质谱法直接检测血清中单克隆游离轻链, objectType=article, longId=181586, objectId=ec6318158639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec6318158639, replyNumber=0, likeNumber=42, createdTime=2020-01-09, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec6318158639, moduleTitle=Clin Chem：免疫富集-偶联MALDI-TOF质谱法直接检测血清中单克隆游离轻链, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec6318158639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987488, encodeId=4d81198e488db, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Clinica Chimica Acta：MALDI-TOF质谱测定糖化血红蛋白的评价, objectType=article, longId=184068, objectId=8836184068ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8836184068ed, replyNumber=0, likeNumber=37, createdTime=2019-12-15, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8836184068ed, moduleTitle=Clinica Chimica Acta：MALDI-TOF质谱测定糖化血红蛋白的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8836184068ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987487, encodeId=1267198e48790, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Clinica Chimica Acta：基于UPLC-Q-TOF/MS的非靶向代谢组学方法识别人类尿液中不同严重程度的冠心病生物标志物, objectType=article, longId=183506, objectId=a2641835062b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2641835062b, replyNumber=0, likeNumber=26, createdTime=2020-04-21, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2641835062b, moduleTitle=Clinica Chimica Acta：基于UPLC-Q-TOF/MS的非靶向代谢组学方法识别人类尿液中不同严重程度的冠心病生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2641835062b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987485, encodeId=dbe7198e4856c, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Clinica Chimica Acta：MALDI-TOF质谱分析将daratumumab与m蛋白区分开来, objectType=article, longId=177269, objectId=c6c41e72691e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6c41e72691e, replyNumber=0, likeNumber=30, createdTime=2020-01-11, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6c41e72691e, moduleTitle=Clinica Chimica Acta：MALDI-TOF质谱分析将daratumumab与m蛋白区分开来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6c41e72691e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987483, encodeId=d18e198e483ea, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=PLoS One：感官听力损失患者OTOF变异的大规模并行DNA测序分析, objectType=article, longId=167325, objectId=b9fd16e32573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9fd16e32573, replyNumber=0, likeNumber=31, createdTime=2019-08-28, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9fd16e32573, moduleTitle=PLoS One：感官听力损失患者OTOF变异的大规模并行DNA测序分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9fd16e32573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987482, encodeId=be3a198e48271, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=新型抗抑郁药SpravatoFDA获批, objectType=article, longId=162142, objectId=3b92162142e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b92162142e7, replyNumber=0, likeNumber=40, createdTime=2019-09-02, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b92162142e7, moduleTitle=新型抗抑郁药SpravatoFDA获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b92162142e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987481, encodeId=361e198e481f6, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Clin Gastroenterology H： Tofacitinib诱导疗法可在3天内减轻UC患者的症状, objectType=article, longId=157888, objectId=b0b215e8885a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0b215e8885a, replyNumber=0, likeNumber=30, createdTime=2019-04-07, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0b215e8885a, moduleTitle=Clin Gastroenterology H： Tofacitinib诱导疗法可在3天内减轻UC患者的症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0b215e8885a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987480, encodeId=4594198e4808f, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Curr Genomics：OTOF 中的一个移码突变与听神经病谱系障碍相关, objectType=article, longId=146122, objectId=a66a146122d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a66a146122d4, replyNumber=0, likeNumber=44, createdTime=2018-12-08, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a66a146122d4, moduleTitle=Curr Genomics：OTOF 中的一个移码突变与听神经病谱系障碍相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a66a146122d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987479, encodeId=d8f3198e479a0, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Heart：肺动脉瓣置换术不会降低TOF修复术后患者的死亡风险, objectType=article, longId=136245, objectId=74db136245e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74db136245e0, replyNumber=0, likeNumber=38, createdTime=2019-02-05, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74db136245e0, moduleTitle=Heart：肺动脉瓣置换术不会降低TOF修复术后患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74db136245e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987478, encodeId=14ef198e4780a, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=Am J Neuroradiol：探究TOF MRA与DSA在成人原发性中枢神经系统血管炎中价值的一致性。, objectType=article, longId=107855, objectId=781410e85588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=781410e85588, replyNumber=0, likeNumber=39, createdTime=2018-06-23, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=781410e85588, moduleTitle=Am J Neuroradiol：探究TOF MRA与DSA在成人原发性中枢神经系统血管炎中价值的一致性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=781410e85588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987477, encodeId=9f25198e47742, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=JAMA Dermatol：托法替尼（Tofacitinib）——白癜风治疗的新希望, objectType=article, longId=53256, objectId=8a4653256e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a4653256e4, replyNumber=0, likeNumber=44, createdTime=2016-01-09, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a4653256e4, moduleTitle=JAMA Dermatol：托法替尼（Tofacitinib）——白癜风治疗的新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a4653256e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987476, encodeId=6282198e4766d, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=CSCO 2014：Massimo Cristofanilli：抗癌，我们在一起, objectType=article, longId=40383, objectId=c2c6403832d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2c6403832d, replyNumber=0, likeNumber=43, createdTime=2015-05-02, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2c6403832d, moduleTitle=CSCO 2014：Massimo Cristofanilli：抗癌，我们在一起, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2c6403832d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1987475, encodeId=4419198e47588, content=<a href='/topic/show?id=af031e620cf' target=_blank style='color:#2F92EE;'>#TOF#</a>, objectTitle=辉瑞潜在重磅药物tofacitinib 2个III期研究达主要终点, objectType=article, longId=25277, objectId=4107252e7fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4107252e7fd, replyNumber=0, likeNumber=33, createdTime=2014-03-08, rootId=0, userName=daviiliu, userId=5b3f89, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4107252e7fd, moduleTitle=辉瑞潜在重磅药物tofacitinib 2个III期研究达主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4107252e7fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TOF

2020-05-29

daviiliu (审核中...)

前往app查看评论内容

#TOF#

A&R：鉴定Mitofusin 1和补体成分1q亚成分结合蛋白作为系统性红斑狼疮的线粒体靶点

2022-09-20

daviiliu (审核中...)

前往app查看评论内容

#TOF#

J Am Acad Dermatol：外用JAK-STAT抑制剂Tofacitinib有效减少非特应性皮炎慢性瘙痒

2022-10-02

daviiliu (审核中...)

前往app查看评论内容

#TOF#

European Radiology:应用TOF-MRA，做到颅内动脉狭窄的无创精准分析！

2022-03-14

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Nat Commun：Tofacitinib治疗系统性红斑狼疮的1期临床试验结果

2021-12-05

daviiliu (审核中...)

前往app查看评论内容

#TOF#

XELJANZ（tofacitinib）治疗强直性脊柱炎（AS）：III期研究取得阳性结果

2021-06-19

daviiliu (审核中...)

前往app查看评论内容

#TOF#

NEJM：Tofersen治疗SOD1-ALS

2021-04-30

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Clin Chem：一种应用于尿碱症的全面LC-QTOF-MS代谢表型分析策略研究

2019-11-21

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Clin Chem：免疫富集-偶联MALDI-TOF质谱法直接检测血清中单克隆游离轻链

2020-01-09

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Clinica Chimica Acta：MALDI-TOF质谱测定糖化血红蛋白的评价

2019-12-15

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Clinica Chimica Acta：基于UPLC-Q-TOF/MS的非靶向代谢组学方法识别人类尿液中不同严重程度的冠心病生物标志物

2020-04-21

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Clinica Chimica Acta：MALDI-TOF质谱分析将daratumumab与m蛋白区分开来

2020-01-11

daviiliu (审核中...)

前往app查看评论内容

#TOF#

PLoS One：感官听力损失患者OTOF变异的大规模并行DNA测序分析

2019-08-28

daviiliu (审核中...)

前往app查看评论内容

#TOF#

新型抗抑郁药SpravatoFDA获批

2019-09-02

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Clin Gastroenterology H： Tofacitinib诱导疗法可在3天内减轻UC患者的症状

2019-04-07

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Curr Genomics：OTOF 中的一个移码突变与听神经病谱系障碍相关

2018-12-08

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Heart：肺动脉瓣置换术不会降低TOF修复术后患者的死亡风险

2019-02-05

daviiliu (审核中...)

前往app查看评论内容

#TOF#

Am J Neuroradiol：探究TOF MRA与DSA在成人原发性中枢神经系统血管炎中价值的一致性。

2018-06-23

daviiliu (审核中...)

前往app查看评论内容

#TOF#

JAMA Dermatol：托法替尼（Tofacitinib）——白癜风治疗的新希望

2016-01-09

daviiliu (审核中...)

前往app查看评论内容

#TOF#

CSCO 2014：Massimo Cristofanilli：抗癌，我们在一起

2015-05-02

daviiliu (审核中...)

前往app查看评论内容

#TOF#

辉瑞潜在重磅药物tofacitinib 2个III期研究达主要终点

2014-03-08

科室
- - 订阅+
  - 更多科室
工具
服务